Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Renal Artery Denervation In Addition to Catheter Ablation To Eliminate Atrial Fibrillation (ERADICATE--AF)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2015 by Meshalkin Research Institute of Pathology of Circulation
Sponsor:
Information provided by (Responsible Party):
Meshalkin Research Institute of Pathology of Circulation
ClinicalTrials.gov Identifier:
NCT01873352
First received: June 5, 2013
Last updated: September 24, 2015
Last verified: September 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2017
  Estimated Primary Completion Date: October 2016 (Final data collection date for primary outcome measure)